Stay updated on DTG vs EFV for HIV-TB Coinfection Clinical Trial
Sign up to get notified when there's something new on the DTG vs EFV for HIV-TB Coinfection Clinical Trial page.

Latest updates to the DTG vs EFV for HIV-TB Coinfection Clinical Trial page
- CheckyesterdayChange DetectedThe new screenshot shows only formatting and layout adjustments with no changes to core study data, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check30 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference2%

- Check37 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content or data appears to be altered.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, signaling a new release. The 'Back to Top' link has been removed.SummaryDifference0.1%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.1%

- Check66 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as updated drug information for Dolutegravir and Efavirenz. Additionally, several MedlinePlus related topics have been added, enhancing the content related to HIV.SummaryDifference2%

Stay in the know with updates to DTG vs EFV for HIV-TB Coinfection Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTG vs EFV for HIV-TB Coinfection Clinical Trial page.